Veterinary products specialist Eco Animal Health (LON:EAH) saw its revenues climb by 9.4% to £67.2 million over the year ended 31st March driven by a strong performance for the company’s flagship treatments for pigs and poultry. Sales were strong in the United States and South East Asia, but struggled in Brazil where they fell by 25%.
EBITDA rose by 15% to £19.6 million due to a renewed focus on higher margin products and management have recommended that the full year dividend by raised to 9.2p from 7.1p. Executive Chairman Peter Lawrence said that the current year had gotten off to a good start and that the company’s “sound balance sheet and consistent cash generation place the company in a strong position to take advantage of any opportunity that may arise“. Shares in Eco Animal Health were 547.50 at 13:30 BST, up by 2.3% over the last close.